| Tretinoin | Approved Investigational Nutraceutical | NEU4 | 129807 |
upregulated | Tretinoin results in increased expression of NEU4 mRNA | 2q37.3 | |
| Tretinoin | Approved Investigational Nutraceutical | NEURL1 | 9148 |
downregulated | Tretinoin results in decreased expression of NEURL1 mRNA | 10q24.33 | |
| Tretinoin | Approved Investigational Nutraceutical | NEURL3 | 93082 |
upregulated | Tretinoin results in increased expression of NEURL3 mRNA | 2q11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | NEUROD1 | 4760 |
upregulated | Tretinoin results in increased expression of NEUROD1 mRNA | 2q31.3 | |
| Tretinoin | Approved Investigational Nutraceutical | NEUROG1 | 4762 |
upregulated | Tretinoin results in increased expression of NEUROG1 mRNA | 5q31.1 | |
| Tretinoin | Approved Investigational Nutraceutical | NEUROG2 | 63973 |
downregulated | Tretinoin results in decreased expression of NEUROG2 mRNA | 4q25 | |
| Tretinoin | Approved Investigational Nutraceutical | NF1 | 4763 |
upregulated | Tretinoin results in increased expression of NF1 mRNA | 17q11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | NFASC | 23114 |
upregulated | Tretinoin results in increased expression of NFASC mRNA | 1q32.1 | |
| Tretinoin | Approved Investigational Nutraceutical | NFAT5 | 10725 |
upregulated | Tretinoin results in increased expression of NFAT5 mRNA | 16q22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | NFE2 | 4778 |
upregulated | Tretinoin results in increased expression of NFE2 mRNA | 12q13 | |
| Tretinoin | Approved Investigational Nutraceutical | NFE2L2 | 4780 |
downregulated | Tretinoin results in decreased expression of NFE2L2 mRNA | 2q31.2 | |
| Tretinoin | Approved Investigational Nutraceutical | NFE2L2 | 4780 |
upregulated | Tretinoin results in increased expression of NFE2L2 mRNA | 2q31.2 | |
| Tretinoin | Approved Investigational Nutraceutical | NFE2L3 | 9603 |
downregulated | Tretinoin results in decreased expression of NFE2L3 mRNA | 7p15.2 | |
| Tretinoin | Approved Investigational Nutraceutical | NFIA | 4774 |
upregulated | Tretinoin results in increased expression of NFIA mRNA | 1p31.3 | |
| Tretinoin | Approved Investigational Nutraceutical | NFIB | 4781 |
upregulated | Tretinoin results in increased expression of NFIB mRNA | 9p23-p22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | NFKBIA | 4792 |
downregulated | Tretinoin results in decreased expression of NFKBIA mRNA | 14q13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | NFKBIZ | 64332 |
upregulated | Tretinoin results in increased expression of NFKBIZ mRNA | 3q12.3 | |
| Tretinoin | Approved Investigational Nutraceutical | NFS1 | 9054 |
downregulated | Tretinoin results in decreased expression of NFS1 mRNA | 20q11.22 | |
| Tretinoin | Approved Investigational Nutraceutical | NFYA | 4800 |
upregulated | Tretinoin results in increased expression of NFYA mRNA | 6p21.1 | |
| Tretinoin | Approved Investigational Nutraceutical | NFYB | 4801 |
downregulated | Tretinoin results in decreased expression of NFYB mRNA | 12q23.3 | |
| Tretinoin | Approved Investigational Nutraceutical | NHS | 4810 |
downregulated | Tretinoin results in decreased expression of NHS mRNA | Xp22.2-p22.13 | |
| Tretinoin | Approved Investigational Nutraceutical | NID1 | 4811 |
upregulated | Tretinoin results in increased expression of NID1 mRNA | 1q42.3 | |
| Tretinoin | Approved Investigational Nutraceutical | NIFK | 84365 |
downregulated | Tretinoin results in decreased expression of NIFK mRNA | 2q14.3 | |
| Tretinoin | Approved Investigational Nutraceutical | NINJ1 | 4814 |
upregulated | Tretinoin results in increased expression of NINJ1 mRNA | 9q22.31 | |
| Tretinoin | Approved Investigational Nutraceutical | NIPAL1 | 152519 |
upregulated | Tretinoin results in increased expression of NIPAL1 mRNA | 4p12 | |